LATEST NEWS

Mar 6, 2022

N-LIfT cell therapy shows complete and superior cell killing in solid tumour organoid

London, 6th March 2022 – LIfT BioSciences,a biotech bringing to market a first-in-class allogeneic innate cell therapy, today announces...

Jan 21, 2022

LIfT BioSciences secures its largest financing to date with a further £5m

London, 21st January 2022 – Biotech LIfT BioSciences today announced its largest financing round to date with a further £5m investment...

Mar 26, 2021

LIfT BioSciences & King’s College London embark on an exciting new collaboration

London, 26 March – LIfT BioSciences announced today that they have embarked on a collaboration with King’s College London, under the...